Neena Patil was Appointed as General Counsel at Abeona-Therapeutics

Date of management change: October 19, 2018 

What Happened?

New York, -based Abeona-Therapeutics Appointed Neena Patil as General Counsel


About the Company

Abeona Therapeutics Inc.(NASDAQ: $ABEO)is a leading clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Abeona`s lead programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV-NAGLU), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type B (MPS IIIB). Abeona is also developing ABO-201 (AAV-CLN3) gene therapy for CLN3 disease, ABO-202 (AAV-CLN1) for treatment of CLN1 disease, EB-201 for epidermolysis bullosa (EB), ABO-301 (AAV-FANCC) for Fanconi anemia (FA) disorder and ABO-302 using a novel CRISPR/Cas9-based gene editing approach to gene therapy for rare blood diseases. In addition, Abeona is developing a proprietary vector platform, AIM™, for next generation product candidates.


About the Person

Neena Patil is General Counsel at Abeona Therapeutics. Previously, Neena held various senior legal leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Igoe Paul, Tyler Tant, Lee Cynthia, McDonald Susanna, Siegel Kenneth, Constantin Charles, Cohen Jordan, Daves Fern, Gable Erin, Burgess Mia, Anderson David

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.